CTLA-4

If it's on your mind and it has to do with multiple sclerosis in any way, post it here.
Post Reply
User avatar
Petr75
Family Elder
Posts: 1610
Joined: Sat Oct 19, 2013 10:17 am
Location: Czech Republic
Contact:

CTLA-4

Post by Petr75 »

2021 Jun 7
Clinical Neurosciences, Translational Health Sciences, Bristol Medical School, University of Bristol, Bristol, UK/North Bristol NHS Trust, Bristol, UK
CNS demyelination associated with immune dysregulation and a novel CTLA-4 variant
https://pubmed.ncbi.nlm.nih.gov/34097529/

Abstract

Background: The cytotoxic T-lymphocyte antigen-4 (CTLA-4) pathway acts as a negative immune regulator of T-cell activation and promotes self-tolerance.

Case: We report the first case of biopsy-proven central nervous system inflammatory demyelination in the context of primary immunodeficiency and a novel CTLA-4 variant.

Conclusion: This case has significant implications for the development of novel treatments for autoimmune conditions including multiple sclerosis and further emphasises the need for caution with clinical use of CTLA-4 immune checkpoint inhibitors in those with a history of inflammatory demyelination.
https://www.eboro.cz
Post Reply

Return to “General Discussion”